The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies

SYN-004 (ribaxamase) is a β-lactamase designed to be orally administered concurrently with intravenous β-lactam antibiotics, including most penicillins and cephalosporins. Ribaxamase's anticipated mechanism of action is to degrade excess β-lactam antibiotic that is excreted into the small intes...

Descripción completa

Detalles Bibliográficos
Autores principales: Kokai-Kun, John F., Roberts, Tracey, Coughlin, Olivia, Sicard, Eric, Rufiange, Marianne, Fedorak, Richard, Carter, Christian, Adams, Marijke H., Longstreth, James, Whalen, Heidi, Sliman, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328510/
https://www.ncbi.nlm.nih.gov/pubmed/28052855
http://dx.doi.org/10.1128/AAC.02197-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328510/
https://www.ncbi.nlm.nih.gov/pubmed/28052855
http://dx.doi.org/10.1128/AAC.02197-16

Ejemplares similares